| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8613616 | Clinical Genitourinary Cancer | 2018 | 7 Pages |
Abstract
This nomogram may be a useful tool to interpret results of nonrandomized phase 2 trials of salvage therapy for metastatic urothelial carcinoma by assessing the OS contributions of drug intervention independent of prognostic variables.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Guru Sonpavde, Gregory Russell Pond, Jonathan E. Rosenberg, Toni K. Choueiri, Joaquim Bellmunt, Ashley Marie Regazzi, Stephanie A. Mullane, Andrea Necchi, Daniele Raggi, Jae-Lyun Lee, Soonil Lee, Joe Simpson, Christina Louise Derleth, Shih-Wen Lin,